| AD12 |
|
Alzheimer disease 12
|
|
|
0.711 |
0.538 |
| H3P37 |
|
H3 histone pseudogene 37
|
|
|
0.780 |
0.269 |
| MIR526B |
|
microRNA 526b
|
|
|
0.821 |
0.192 |
| CYP21A1P |
|
cytochrome P450 family 21 subfamily A member 1, pseudogene
|
|
|
0.780 |
0.500 |
| IGHV3-75 |
|
immunoglobulin heavy variable 3-75 (pseudogene)
|
|
|
0.769 |
0.231 |
| MIR657 |
|
microRNA 657
|
|
|
0.861 |
0.269 |
| CCR5AS |
|
CCR5 antisense RNA
|
|
|
0.805 |
0.115 |
| EGI |
|
epilepsy, generalized, idiopathic
|
|
|
0.861 |
0.077 |
| OLA1P2 |
|
OLA1 pseudogene 2
|
|
|
0.931 |
0.077 |
| DEFT1P |
|
defensin theta 1, pseudogene
|
|
|
0.931 |
0.077 |
| FRA18B |
|
fragile site, aphidicolin type, common, fra(18)(q21.3)
|
|
|
1.000 |
0.038 |
| IV |
|
inversus situs, viscerum
|
|
|
1.000 |
0.077 |
| MYOCOS |
A0A1B0GUC4
|
myocilin opposite strand
|
|
|
0.805 |
0.192 |
| IRGM |
A1A4Y4
|
immunity related GTPase M
|
|
|
0.617 |
0.538 |
| NBAS |
A2RRP1
|
NBAS subunit of NRZ tethering complex
|
|
5.0E-43 |
0.566 |
0.692 |
| POTEF |
A5A3E0
|
POTE ankyrin domain family member F
|
|
5.5E-06 |
0.481 |
0.885 |
| SMCHD1 |
A6NHR9
|
structural maintenance of chromosomes flexible hinge domain containing 1
|
|
1.00 |
0.631 |
0.615 |
| ARVCF |
O00192
|
ARVCF delta catenin family member
|
Cellular structure
|
5.0E-11 |
0.540 |
0.769 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
| APBB1 |
O00213
|
amyloid beta precursor protein binding family B member 1
|
|
0.97 |
0.722 |
0.346 |
| PSMD9 |
O00233
|
proteasome 26S subunit, non-ATPase 9
|
Enzyme modulator
|
4.9E-06 |
0.435 |
0.846 |
| BMPR1B |
O00238
|
bone morphogenetic protein receptor type 1B
|
Kinase
|
1.00 |
0.573 |
0.615 |
| AGRP |
O00253
|
agouti related neuropeptide
|
Signaling
|
7.0E-04 |
0.488 |
0.769 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| DCTN6 |
O00399
|
dynactin subunit 6
|
Cellular structure
|
5.6E-02 |
0.442 |
0.769 |